Top 5 Drug Products Advertised in Professional Health Journals (Dollars) through April 2013

by Client Services

Xarelto maintained its spot as the top drug product (by dollars) advertising in professional health journals year-to-date, according to Kantar Media. Linzess replaced Tudorza Pressair Inhalation Powder as second on the list.

Top 5 Print Ad Drugs (Dollars): Jan. – April 2013

#1 Xarelto Tablets – $6 MM (+33%)

#2 Linzess Capsules – $4 MM (N/A)

#3 Tudorza Pressair Inhalation Powder– $4 MM (N/A)

#4 Zytiga – $2 MM (+69%)

#5 Lyrica Capsules – $2 MM (+65%)

Xarelto ranked #3 at this time in 2012, while both Linzess and Tudorza Pressair Inhalation Powder did not appear on the list. Xarelto is an anticoagulant is used to prevent the formation of blood clots. It’s also used by individuals with heart rhythm disorders to lower the risk of stroke caused by a blood clot.

The percentage changes compare January – April 2013 to that same time period in 2012. For more information on these ad insights or other data, let one of us know.

Kantar Media sets the standard for accurate, comprehensive competitive advertising intelligence in the professional healthcare arena. Check back next month for updated data on the top products, classes, companies and category movers year-to-date.